Ernexa Therapeutics ERNAW
NASDAQ ERNAW
$0.06 +0.01 (+25.27%)
As of: Sep 4, 2026 · 3:55 PM EDT

Ernexa Therapeutics (ERNAW) EBT Margin (QoQ) (2010 - 2024)

Analysis

Ernexa Therapeutics (ERNAW) EBT Margin (QoQ) (2010 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ernexa Therapeutics 67,312.70 67,312.70 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.49 Mn
Sep 30, 2024 629,708.00
Jun 30, 2024 237,660.00
Mar 31, 2024 -156,874.00
Dec 31, 2023 -158,687.00
Dec 31, 2020 -11,512.00
Mar 31, 2020 -2,659.00
Dec 31, 2019 -1,783.00
Sep 30, 2019 -553.00
Jun 30, 2019 453.00
Mar 31, 2019 -544.00
Dec 31, 2018 -468.00
Sep 30, 2018 563.00
Jun 30, 2018 530.00
Mar 31, 2018 415.00
Dec 31, 2017 -785.00
Sep 30, 2017 -52.00
Jun 30, 2017 -124.00
Mar 31, 2017 595.00
Dec 31, 2016 284.00